B. Py and H. T. , Varicella in non-immune persons: incidence, hospitalization and mortality rates, Epidemiol. Infect, vol.129, pp.599-606, 2002.

K. Pe, K. Seward-jf, and A. Jumaan, Varicella in Americans from NHANES III: implications for control through routine immunization, J. Med. Virol, vol.70, pp.111-118, 2003.

A. S. Evans and R. A. Kaslow, Viral Infections of Humans: Epidemiology and Control. Fourth Edition, p.1083, 1997.

G. Tl, L. Gb, B. Er, W. Hutcheson-rh, and S. W. Pf, An outbreak of airborne nosocomial varicella, Pediatrics, vol.70, pp.550-556, 1982.

Z. C. , V. Kries-r, L. R. , W. J. , and S. Hj, Severe complications of varicella in previously healthy children in Germany: a 1-year survey, Pediatrics, vol.108, pp.1-6, 2001.

C. Pw, D. Jg, and P. R. Manson-je, The epidemiology of varicella and its complications, J. Infect. Dis, vol.172, pp.706-712, 1995.

E. Brisson-m, . Wj, and . Law-b, Epidemiology of varicella zoster virus infection in Canada and the United Kingdom, Epidemiol. Infect, vol.127, issue.2, pp.305-314, 2001.

F. Pédiatrique-en, Caractéristiques cliniques des varicelles hospitalisées en réanimation pédiatrique de, BEH, vol.09, pp.51-52, 1998.

. Recommandations-vaccinales-contre-la-varicelle, ré-évaluation des recommandations relatives à la vaccination contre la varicelle avec l'arrivée de vaccins quadrivalents rougeole-rubéole-oreillons-varicelle, 2007.

P. A. , L. M. Schick-b, Z. C. , F. M. , and G. M. , Outcome after maternel varicella infection in the first 20 weeks of pregnancy, N. Engl. J. Med, vol.330, pp.901-905, 1994.

M. V. , L. P. Varicelle-et-grossesse, ». In, G. , and A. F. , Infections virales et toxoplasmose materno, pp.73-86, 2001.

P. Sr, V. Bregman-dj, and . Ll, Deaths from varicella in infants, Pediatr Infect Dis J, vol.4, pp.503-507, 1985.

P. Sr, Varicella: complications and costs, Pediatrics, vol.78, pp.728-735, 1986.

G. Chiappe-s, S. M. , T. C. , L. A. , P. C. et al., Herpes zoster: burden of disease in France, Vaccine, vol.8, pp.7933-7938, 2010.

H. Re, The nature of herpes zoster: a long-term study and a new hypothesis, Proc. R. Soc. Med, vol.58, pp.9-20, 1965.

C. C. , B. J. , D. Jp, H. , M. P. et al., Characteristics of patients with herpes zoster on presentation to practitioners in France, Clin. Infect. Dis, vol.33, pp.62-69, 2001.

C. Pw, G. K. , D. Jg, W. Am, S. D. et al., Risk factors for postherpetic neuralgia, Arch. Intern. Med, vol.157, p.12171224, 1997.

H. S. , P. G. , G. S. , and S. Ja, Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up, BMJ, vol.321, p.7946, 2000.

W. Re, K. Bj, and . Neff-bj, Live Oka/Merck varicella vaccine in healthy children, JAMA, vol.254, pp.2435-2439, 1985.

V. M. Larussa-ps, G. A. , N. L. Muehlenbein-ce, and . Steinberg-sp, Effectiveness over time of varicella vacine, JAMA, vol.291, pp.851-855, 2004.

W. Re, N. Bj, and K. Bj, Live attenuated varicella virus vaccine: efficacy trial in healthy children, N. Engl. J. Med, vol.310, pp.1409-1415, 1984.

G. Aa, S. Sp, and L. P. , Immunization of healthy adults with live attenuated varicella vaccine, J. Infect. Dis, vol.158, pp.132-137, 1988.

M. F. , D. Bonver-jl, and . Vandevoorde-d, Immunogenicity and safety of a live attenuated varicella vaccine (Oka/SB Bio) in healthy children, J. Infect. Dis, vol.174, issue.3, pp.324-329, 1996.

K. Bj, W. Re, and G. H. Oka, Merck varicella vaccine in healthy children: final report of a 2 year efficacy study and 7-year follow-up studies, Vaccine, vol.9, pp.643-647, 1991.

F. Mj, Varicella vaccine in post-exposure prophylaxis, Commun. Dis. Intell, vol.25, issue.1, pp.13-15, 2001.

M. M. , G. D. , and C. Ss, Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm